Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients

被引:2
|
作者
Mathiesen, P. R. [1 ]
Zak, M. [2 ]
Herlin, T. [3 ]
Nielsen, S. M. [2 ]
机构
[1] Copenhagen Univ Hosp, Dept Paediat, Paediat Clin, DK-4300 Holbaek, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Paediat Rheumatol Unit, DK-4300 Holbaek, Denmark
[3] Aarhus Univ Hosp, Paediat Rheumatol Clin, Aarhus, Denmark
关键词
Juvenile dermatomyositis; outcome assessments; Myositis Damage Index; calcinosis; IDIOPATHIC INFLAMMATORY MYOPATHIES; NATIONAL-INSTITUTE; PROGNOSTIC-FACTORS; DISEASE; POLYMYOSITIS; ARTHRITIS; CHILDREN; DAMAGE; ONSET; MUSCULOSKELETAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess disease characteristics and outcome in Danish juvenile dermatomyositis (JDM) patients (1977-2007). Methods Medical record review of hospital records identified from the National Patient Register. Results Fifty-seven JDM patients were identified. Follow-up time was 7 years (range 0.06-30). Female:male ratio was 2.5:1. Mean age at disease onset was 7 years (SD +/- 3.7), range 1.5-16.0 years. Diagnostic delay was 0.7 years (SD +/- 1.6), range 0.04-9 years. Mean disease duration was 3.7 years (SD +/- 3.5), range 0.7-9 years. Thirty-nine patients (70%) were in full remission. Three patients (5%) were deceased. Disease/treatment-induced damage was present in 35 (61%) patients. Decreased pulmonary function occurred early in the disease course (median 10 months), osteoporosis and calcinosis occurred later (median 18 and 22 months). Four patients developed persistent damage within the first 6 months, four developed calcinosis within the first year. Shorter disease duration was associated with less damage (p=0.004). In a multivariate assessment analysis age > 10 years at disease onset was associated with more damage (p < 0.01), OR 10.96 (CI 1.6-73.6), and disease duration > 4 years was associated with calcinosis (p=0.01) OR 23.2 (CI 2.6-206.2). Conclusion We present a nationwide retrospective study of Danish JDM patients from 1977-2007. Although 70% were in remission, 61% of the patients had clinical signs of damage. Only a few patients developed damage within the first year of the disease. Longer disease duration and higher age at disease onset was correlated with more disease damage.
引用
收藏
页码:782 / 789
页数:8
相关论文
共 50 条
  • [21] Clinical Analysis and Outcome of Interstitial Lung Disease with Juvenile Dermatomyositis
    Sato, Satoshi
    Uejima, Yoji
    Suganuma, Eisuke
    Takano, Tadamasa
    Kawano, Yutaka
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Histological features in juvenile dermatomyositis may predict clinical progression
    Li, CKC
    Holton, JL
    Varsani, H
    Woo, P
    Wedderburn, LR
    RHEUMATOLOGY, 2005, 44 : I92 - I93
  • [23] Inflammatory milieu of muscle biopsies and clinical features in juvenile dermatomyositis
    Sag, E.
    Ozen, S.
    Kale, G.
    Topaloglu, H.
    Talim, B.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S248 - S248
  • [24] Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis
    Mamyrova, Gulnara
    Kishi, Takayuki
    Targoff, Ira N.
    Ehrlich, Alison
    Curiel, Rodolfo V.
    Rider, Lisa G.
    Abramson, Leslie S.
    Arabshahi, Bita
    Cartwright, Victoria
    Chalom, Elizabeth J.
    Eberhardt, Barbara Anne
    Hannan, William
    Higgins, Gloria C.
    Fuhlbrigge, Robert C.
    Jacobs, Jerry C.
    Jung, Lawrence
    Kimura, Yukiko
    Lindsley, Carol B.
    Martin, Alan L.
    Miller, Frederick W.
    Milojevic, Diana
    Ostrov, Barbara E.
    Perez, Maria D.
    Rivas-Chacon, Rafael F.
    Rosenkranz, Margalit
    Sherry, David D.
    Soep, Jennifer
    Sule, Sangeeta
    Vogelgesang, Scott A.
    RHEUMATOLOGY, 2018, 57 (11) : 1956 - 1963
  • [25] Juvenile Psoriatic Arthritis (JPsA) clinical features and outcome of 119 patients
    Y Butbul Aviel
    PN Tyrrell
    BM Feldman
    RM Laxer
    RK Saurenmann
    L Spiegel
    B Cameron
    S Tse
    ED Silverman
    Pediatric Rheumatology, 6 (Suppl 1)
  • [26] Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis
    Sato, Satoshi
    Uejima, Yoji
    Nanbu, Meika
    Suganuma, Eisuke
    Takano, Tadamasa
    Tanaka, Risa
    Kabuki, Tomoyuki
    Oguma, Eiji
    Oh-Ishi, Tsutomu
    Kawano, Yutaka
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 652 - 656
  • [27] Demographics, Clinical Features and Therapies of Patients with Juvenile Dermatomyositis Participating in a National Myositis Patient Registry
    Rider, Lisa G.
    Faiq, Abdullah
    Farhadi, Payam Noroozi
    Bayat, Nastaran
    Itert, Lukasz
    Chase, Mikaela
    Ulrey, Robert
    Malley, Karen
    Wilkerson, Jesse
    Johnson, Anne
    Rose, Kathryn
    Morris, Richard
    Parks, Christine
    Giannini, Edward H.
    Brunner, Hermine
    Goldberg, Bob
    Miller, Frederick W.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S86 - S87
  • [28] Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis
    Guseinova, D.
    Consolaro, A.
    Trail, L.
    Ferrari, C.
    Pistorio, A.
    Ruperto, N.
    Buoncompagni, A.
    Pilkington, C.
    Maillard, S.
    Oliveira, S. K.
    Sztajnbok, F.
    Cuttica, R.
    Corona, F.
    Katsicas, M. M.
    Russo, R.
    Ferriani, V.
    Burgos-Vargas, R.
    Solis-Vallejo, E.
    Bandeira, M.
    Baca, V.
    Saad-Magalhaes, C.
    Silva, C. A.
    Barcellona, R.
    Breda, L.
    Cimaz, R.
    Gallizzi, R.
    Garozzo, R.
    Martino, S.
    Meini, A.
    Stabile, A.
    Martini, A.
    Ravelli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 117 - 124
  • [29] Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study
    Jiang, Wei
    Yang, Hanbo
    Li, Sizhao
    Tian, Xiaolan
    Wang, Guochun
    RHEUMATOLOGY, 2021, 60 (06) : 2958 - 2962
  • [30] Sensitivity of the bohan and peter criteria in a cohort of patients with juvenile dermatomyositis
    Palmisani, E.
    Sanchez-Cuevas, M.
    Avendano, G. D. B.
    Magni-Manzoni, S.
    Labo, E.
    Alpigiani, M.
    Trail, L.
    Viola, S.
    Buoncompagni, A.
    Pistorio, A.
    Martini, A.
    Ravelli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 450 - 451